galactosylceramides

Preferred Label : galactosylceramides;

MeSH definition : Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy.;

MeSH synonym : galactosyl ceramides; ceramides, galactosyl; galactocerebrosides; Galactosyl Ceramide; Ceramide, Galactosyl; Galactosylceramide;

Wikipedia link : https://en.wikipedia.org/wiki/Galactosylceramide;

Is substance : O;

Détails

Origin ID

D005699;

UMLS CUI

C0016960;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Galactocerebroside (substance) [SNOMED CT concept]
- Galactosylceramide [FMA entity]
- galactocerebroside [SNOMED Notion]
Record concept(s)
- galactosylceramides [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-O-(galactopyranosyl)-2-hexacosanoylamino-3,3-difluoro-heptadecane [MeSH Supplementary Concept]
- 1-O-galactopyranosyl-N-(10-(1-pyrene-9-enedecanoyl)sphingosine) [MeSH Supplementary Concept]
- 2',2'-difluoro KRN7000 [MeSH Supplementary Concept]
- 2-amino-1-galactopyranosyloxy-3,4-dihydroxyoctadecane [MeSH Supplementary Concept]
- 3-fluoro-2-hexacosanoylamino-1-(galactopyranosyl)heptadecane [MeSH Supplementary Concept]
- 4-deoxy-4,4-difluoro-KRN7000 [MeSH Supplementary Concept]
- 4-hydroxy-3-nitrophenylgalactosylceramide [MeSH Supplementary Concept]
- 7DW8-5 glycolipid [MeSH Supplementary Concept]
- ABX196 [MeSH Supplementary Concept]
- AGL 517 [MeSH Supplementary Concept]
- C-galactosylceramide [MeSH Supplementary Concept]
- CNC-2 galactocerebroside [MeSH Supplementary Concept]
- DB06-1 compound [MeSH Supplementary Concept]
- KRN 7000 [MeSH Supplementary Concept]
- N-lignocerylgalactosylsphingosine [MeSH Supplementary Concept]
- N-nervonylgalactosylsphingosine [MeSH Supplementary Concept]
- N-palmitoylgalactosylsphingosine [MeSH Supplementary Concept]
- NBD-galactosylceramide [MeSH Supplementary Concept]
- PBS 57 [MeSH Supplementary Concept]
- PBS-44 [MeSH Supplementary Concept]
- RCAI-172 [MeSH Supplementary Concept]
- agelasphin 11 [MeSH Supplementary Concept]
- alpha-S-galactosylceramide [MeSH Supplementary Concept]
- alpha-Se-GalCer [MeSH Supplementary Concept]
- alpha-carba-galactosylceramide [MeSH Supplementary Concept]
- alpha-galactosylceramide [MeSH Supplementary Concept]
- azido-galactosylceramide [MeSH Supplementary Concept]
- biotin-galactosylceramide [MeSH Supplementary Concept]
- clarhamnoside [MeSH Supplementary Concept]
- galactocerebroside [MeSH Supplementary Concept]
- sulfogalactocerebroside [MeSH Supplementary Concept]
- suppressor glycolipid S23 [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Galactosylceramide [FMA entity]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients